"As of April 26th, our team will provide cancer care at Dana-Farber/Brigham and Women’s Cancer Center in clinical affiliation with South Shore Hospital (DF/BWCC SSH) located at 101 Columbian Street, So. Weymouth, MA. The medical oncology physician suite at 51 Performance Drive will close. The DF/BWCC at SSH Department of Radiation Oncology will continue normal operations at the following addresses: • 51 Performance Drive, Weymouth, MA • 101 Columbian Street, S. Weymouth, MA"

During the past decade, Dana Farber Community Cancer Care-Weymouth conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dana Farber Community Cancer Care-Weymouth" #1 collaborator was "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "American College of Surgeons" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Dana Farber Community Cancer Care-Weymouth" are "Breast Adenocarcinoma" (1 trials), "Colon Mucinous Adenocarcinoma" (1 trials), "Colon Signet Ring Cell Adenocarcinoma" (1 trials), "DS Stage I Plasma Cell Myeloma" (1 trials) and "DS Stage II Plasma Cell Myeloma" (1 trials). Many other conditions were trialed in "Dana Farber Community Cancer Care-Weymouth" in a lesser frequency.

Most popular intervention types in "Dana Farber Community Cancer Care-Weymouth" are "Drug" (4 trials), "Other" (4 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Bevacizumab" (2 trials), "Anastrozole" (1 trials), "Bortezomib" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dana Farber Community Cancer Care-Weymouth" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Dana Farber Community Cancer Care-Weymouth". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Dana Farber Community Cancer Care-Weymouth, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dana Farber Community Cancer Care-Weymouth, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".